BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 39 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,000 | -52.0% | 49,148 | 0.0% | 0.00% | – |
| Q2 2022 | $25,000 | -95.1% | 49,148 | -80.4% | 0.00% | – |
| Q1 2022 | $514,000 | -53.9% | 250,768 | -6.2% | 0.00% | – |
| Q4 2021 | $1,116,000 | -54.1% | 267,452 | +2.4% | 0.00% | – |
| Q3 2021 | $2,429,000 | -41.5% | 261,226 | +13.3% | 0.00% | -100.0% |
| Q2 2021 | $4,152,000 | – | 230,529 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJ WEALTH STRATEGIES, LLC | 36,001 | $0 | 0.00% |